{"id":2102,"date":"2026-06-07T12:00:00","date_gmt":"2026-06-07T15:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2102"},"modified":"2026-06-07T12:00:00","modified_gmt":"2026-06-07T15:00:00","slug":"pgrss-tireoide-paratireoide-oncologica-tireoidectomia-paratireoidectomia-i-131-mibi-pet","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-tireoide-paratireoide-oncologica-tireoidectomia-paratireoidectomia-i-131-mibi-pet\/","title":{"rendered":"PGRSS tireoide: tireoidec, paratireoidec, I-131"},"content":{"rendered":"<p>A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente desafiada por gestores de centros de cirurgia tireoide+paratireoide. Em 2026, h\u00e1 uma demanda crescente de hospitais com unidade tireoide oncol\u00f3gica \u2014 <strong>carcinoma papil\u00edfero de tireoide CPT<\/strong> 80% mais comum + <strong>carcinoma folicular CFT<\/strong> 10% + <strong>carcinoma medular CMT<\/strong> 5% RET-mutado + <strong>carcinoma anapl\u00e1sico CAT<\/strong> 1% letal + <strong>linfoma tireoide<\/strong> raro, <strong>tireoidectomia total + esvaziamento cervical central VI + lateral II-V<\/strong> com bisturi Harmonic Focus \/ LigaSure Small Jaw + monitor neurofisiol\u00f3gico nervo lar\u00edngeo recorrente NIM-Response Medtronic R$ 80-150k + identifica\u00e7\u00e3o de paratireoide preservada + iPTH intraoperat\u00f3rio Quick PTH, <strong>paratireoidectomia<\/strong> com PHPT prim\u00e1rio + secund\u00e1rio renal + terci\u00e1rio p\u00f3s-TX renal + ect\u00f3pica intrator\u00e1cica + cintilografia 99mTc-MIBI dual-phase + 4D-CT preop + iPTH intraop, <strong>iodo radioativo I-131 abla\u00e7\u00e3o<\/strong> dose 30-150 mCi p\u00f3s-tireoidectomia para diferenciado + livro CNEN-NN-3.05 + reten\u00e7\u00e3o 5y + isolamento radiol\u00f3gico 24-72h + EPI radioprote\u00e7\u00e3o + descarte espec\u00edfico, <strong>TSH-suppressive levotiroxina Synthroid\/Puran T4<\/strong> dose ajustada por T4-livre + TSH + tireoglobulina Tg + anti-Tg auto-anticorpo, <strong>vandetanib Caprelsa \/ cabozantinib Cometriq<\/strong> TKI MET-RET para CMT progressivo Lista C5 R$ 22-35k\/m\u00eas, <strong>lenvatinib Lenvima \/ sorafenib Nexavar<\/strong> para CDT iodo-refrat\u00e1rio Lista C5, <strong>selpercatinib Retsevmo \/ pralsetinib Gavreto<\/strong> RET-inibidor para CMT RET+ Lista C5 R$ 30-45k\/m\u00eas. A consequ\u00eancia \u00e9 a urg\u00eancia de <strong>PGRSS dedicado para tireoide+paratireoide<\/strong> \u2014 captura de <strong>monitor NIM-Response 3.0 Medtronic<\/strong> R$ 80-150k equipamento + eletrodos descart\u00e1veis NIM-Vital R$ 200-500\/cirurgia + tubo OT espec\u00edfico NIM-Trivantage 7.0-9.0Fr + livro RBI, <strong>iPTH Quick PTH intraoperat\u00f3rio<\/strong> com kit descart\u00e1vel Future Diagnostics + an\u00e1lise immunoradiometric assay 15min, <strong>iodo radioativo I-131 Iodogen<\/strong> abla\u00e7\u00e3o 30-150 mCi com livro CNEN-NN-3.05 + reten\u00e7\u00e3o 5y + transporte SED + EPI radioprote\u00e7\u00e3o plumb\u00edfera + dos\u00edmetro pessoal + monitor \u00e1rea RM3000 \/ CoMo-170 \/ Eberline, <strong>bisturi Harmonic Focus \/ LigaSure Small Jaw<\/strong> R$ 3-5k descart\u00e1vel + clipe Hem-O-Lok M\/L + dreno aspirativo Hemovac\/JP, <strong>scintilografia 99mTc-MIBI<\/strong> dual-phase + cintil\u00f3grafo SPECT\/CT GE Discovery \/ Siemens Symbia \/ Philips BrightView + 4D-CT pr\u00e9-op para localiza\u00e7\u00e3o paratireoide ect\u00f3pica, <strong>vandetanib + cabozantinib + lenvatinib + selpercatinib<\/strong> Lista C5 cofre + cadeia fria + livro 344 + REMS, <strong>TSH recombinante Thyrogen rhTSH<\/strong> Sanofi para prepara\u00e7\u00e3o abla\u00e7\u00e3o Lista C5 R$ 8-15k\/aplica\u00e7\u00e3o. A realidade \u00e9 que tireoide+paratireoide produz RSS de alt\u00edssima complexidade. <strong>PGRSS de tireoide \u00e9 cadeia integrada<\/strong> \u2014 come\u00e7a no <strong>diagn\u00f3stico<\/strong> (US + PAAF + Bethesda + BRAF V600E + RET + cintilografia + 4D-CT), passa pela <strong>terapia<\/strong> (tireoidectomia + esvaziamento + paratireoidec + I-131) e termina no <strong>acompanhamento<\/strong> (Tg + anti-Tg + US + WBS whole-body scan I-131 1y). O conjunto soma <strong>R$ 22.000-48.000\/m\u00eas<\/strong> que muitos gestores subestimam.<\/p>\n<p>Para o gestor que opera ou planeja unidade tireoide+paratireoide, \u00e9 fundamental considerar a complexidade desde o in\u00edcio.<\/p>\n<h2>Os procedimentos tireoide+paratireoide e os RSS espec\u00edficos<\/h2>\n<p>Em uma opera\u00e7\u00e3o de qualquer porte, a cadeia gera RSS espec\u00edficos.<\/p>\n<table>\n<thead>\n<tr>\n<th>Procedimento<\/th>\n<th>Insumo cr\u00edtico<\/th>\n<th>Anatomopatol\u00f3gico<\/th>\n<th>Risco RSS<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Tireoidectomia total<\/td>\n<td>NIM-Response Medtronic+iPTH<\/td>\n<td>Tireoide+linfa 30-150g<\/td>\n<td>A4 + RAEE eletrodo<\/td>\n<\/tr>\n<tr>\n<td>Paratireoidectomia<\/td>\n<td>iPTH Quick PTH 15min<\/td>\n<td>Paratireoide adenoma<\/td>\n<td>A4 + B + ergo<\/td>\n<\/tr>\n<tr>\n<td>I-131 abla\u00e7\u00e3o<\/td>\n<td>C\u00e1psula 30-150 mCi<\/td>\n<td>N\u00e3o-aplic\u00e1vel<\/td>\n<td>A4 + radioativo CNEN<\/td>\n<\/tr>\n<tr>\n<td>TKI vandetanib\/cabozantinib<\/td>\n<td>Comprimido oral<\/td>\n<td>Lista C5 R$ 22-35k\/m\u00eas<\/td>\n<td>A4 + B Lista C5<\/td>\n<\/tr>\n<tr>\n<td>RET selpercatinib<\/td>\n<td>C\u00e1psula RET+<\/td>\n<td>Lista C5 R$ 30-45k\/m\u00eas<\/td>\n<td>A4 + B Lista C5<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A soma t\u00edpica \u00e9 entre <strong>R$ 22.000-48.000\/m\u00eas<\/strong> em PGRSS dedicado de tireoide+paratireoide vs <strong>R$ 8.000-18.000<\/strong> em PGRSS gen\u00e9rico subdimensionado.<\/p>\n<h2>A tireoidectomia + NIM + iPTH: o procedimento de neuromonitoriza\u00e7\u00e3o<\/h2>\n<p>A primeira camada do desafio \u00e9 a tireoidectomia. Padr\u00e3o setorial inclui (a) <strong>acesso cervical<\/strong> colar incision Kocher + flap apron; (b) <strong>monitor NIM-Response 3.0 Medtronic<\/strong> R$ 80-150k equipamento + eletrodos descart\u00e1veis NIM-Vital R$ 200-500\/cirurgia + tubo OT espec\u00edfico NIM-Trivantage 7.0-9.0Fr; (c) <strong>bisturi Harmonic Focus \/ LigaSure Small Jaw<\/strong> R$ 3-5k descart\u00e1vel + clipe Hem-O-Lok M\/L; (d) <strong>iPTH Quick PTH intraoperat\u00f3rio<\/strong> Future Diagnostics 15min para confirma\u00e7\u00e3o curativa paratireoidectomia; (e) <strong>livro RBI tireoide+paratireoide<\/strong> com reten\u00e7\u00e3o 10 anos.<\/p>\n<p>Hospital com 100-300 tireoidectomias\/ano + 30-100 paratireoidectomias\/ano \u00d7 R$ 5k consum\u00edveis = R$ 650k-2M\/ano em cirurgia tireoide + livro RBI. Como discutimos no post sobre <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-otorrino-oncologica-laringectomia-parotidectomia-tonsilo-pescoco-cabeca-tumor-ent\/\">PGRSS de otorrino oncol\u00f3gica<\/a>, neuromonitoriza\u00e7\u00e3o \u00e9 estruturante.<\/p>\n<h2>O I-131 abla\u00e7\u00e3o + radioprote\u00e7\u00e3o CNEN: o est\u00e1gio radioativo<\/h2>\n<p>A segunda camada \u00e9 o I-131. Padr\u00e3o setorial inclui (a) <strong>c\u00e1psula iodo radioativo I-131 Iodogen<\/strong> 30-150 mCi para CDT diferenciado p\u00f3s-tireoidectomia; (b) <strong>isolamento radiol\u00f3gico<\/strong> quarto blindado 24-72h + restri\u00e7\u00e3o contato + descarte espec\u00edfico secre\u00e7\u00f5es; (c) <strong>EPI radioprote\u00e7\u00e3o<\/strong> plumb\u00edfero + dos\u00edmetro pessoal + monitor \u00e1rea RM3000 Aware Electronics \/ CoMo-170 SE International \/ Eberline ESP-2; (d) <strong>TSH recombinante Thyrogen rhTSH<\/strong> Sanofi-Genzyme para prepara\u00e7\u00e3o abla\u00e7\u00e3o Lista C5 R$ 8-15k\/aplica\u00e7\u00e3o alternativa \u00e0 hipotireoidismo agudo; (e) <strong>livro CNEN-NN-3.05<\/strong> com reten\u00e7\u00e3o 5 anos + transporte SED + RT f\u00edsico m\u00e9dico respons\u00e1vel.<\/p>\n<p>Hospital com 100-300 I-131\/ano \u00d7 30-150 mCi m\u00e9dio + 30-50% Thyrogen + livro CNEN = R$ 1-5M\/ano em I-131 + Thyrogen + radioprote\u00e7\u00e3o.<\/p>\n<h2>O TKI sist\u00eamico + RET-inhibitor: o est\u00e1gio Lista C5 targeted<\/h2>\n<p>A terceira camada \u00e9 o targeted. Padr\u00e3o setorial inclui (a) <strong>vandetanib Caprelsa<\/strong> Sanofi RET+VEGFR+EGFR 300mg\/d para CMT progressivo Lista C5 R$ 22-35k\/m\u00eas; (b) <strong>cabozantinib Cometriq<\/strong> Ipsen MET+VEGFR+RET 140mg\/d Lista C5 R$ 25-40k\/m\u00eas; (c) <strong>lenvatinib Lenvima<\/strong> Eisai 24mg\/d para CDT iodo-refrat\u00e1rio Lista C5; (d) <strong>sorafenib Nexavar<\/strong> Bayer alternativa CDT\/CMT; (e) <strong>selpercatinib Retsevmo<\/strong> Lilly + <strong>pralsetinib Gavreto<\/strong> Roche RET-seletivo para CMT RET+ Lista C5 R$ 30-45k\/m\u00eas com sele\u00e7\u00e3o biomarker NGS.<\/p>\n<p>Hospital com 30-100 CMTs\/ano em targeted + 50-150 CDTs iodo-refrat\u00e1rio = R$ 8-65M\/ano em Lista C5 + cofre + livro 344 + REMS.<\/p>\n<h2>Tr\u00eas perfis de PGRSS para tireoide+paratireoide<\/h2>\n<p><strong>PGRSS gen\u00e9rico subdimensionado.<\/strong> Sem cobertura espec\u00edfica para NIM + I-131 + Lista C5 TKI. Custo mensal <strong>R$ 8.000-18.000<\/strong>, efic\u00e1cia limitada.<\/p>\n<p><strong>PGRSS dedicado intermedi\u00e1rio.<\/strong> Cobertura para tireoidectomia + paratireoidec, sem I-131 + RET + Thyrogen. Custo mensal <strong>R$ 18.000-32.000<\/strong>, efic\u00e1cia 100-200%.<\/p>\n<p><strong>PGRSS dedicado completo tireoide+paratireoide.<\/strong> Tireoidec + paratireoidec + I-131 + TKI + RET + Thyrogen + integra\u00e7\u00e3o com <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-endocrinologia-dm1-dm2-tireoide-suprarrenal-hipofise-osteoporose-glp1-insulina\/\">PGRSS de endocrinologia<\/a>. Custo mensal <strong>R$ 32.000-48.000<\/strong>, ROI 250-500%.<\/p>\n<h2>Os tr\u00eas erros que aparecem em PGRSS tireoide+paratireoide subdimensionado<\/h2>\n<p>O primeiro \u00e9 o <strong>subdimensionamento de NIM eletrodos + iPTH<\/strong>. Eletrodos NIM-Vital R$ 200-500\/cirurgia + iPTH 15min s\u00e3o RAEE + livro RBI obrigat\u00f3rio.<\/p>\n<p>O segundo \u00e9 a <strong>aus\u00eancia de livro CNEN I-131 + radioprote\u00e7\u00e3o<\/strong>. 30-150 mCi\/paciente com reten\u00e7\u00e3o 5y + dos\u00edmetro + monitor \u00e1rea.<\/p>\n<p>O terceiro \u00e9 o <strong>descarte de Lista C5 RET-inhibitor como Grupo D<\/strong>. Selpercatinib\/pralsetinib R$ 30-45k\/m\u00eas com cofre + REMS + biomarker NGS.<\/p>\n<p>A regula\u00e7\u00e3o de PGRSS no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com tireoide+paratireoide como prioridade. As institui\u00e7\u00f5es que estruturam PGRSS dedicado desde o in\u00edcio \u2014 alinhadas com <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/calendario-2026-compliance-rss-datas-fiscalizacao\/\">calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o <a href=\"https:\/\/sevenresiduos.com.br\/servicos\/\">portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A <a href=\"https:\/\/www.endocrino.org.br\/\">SBEM Sociedade Brasileira de Endocrinologia e Metabologia<\/a> \u00e9 refer\u00eancia t\u00e9cnica.<\/p>\n<p><strong><a href=\"https:\/\/sevenresiduosaude.com.br\/orcamento\/\">Solicite cota\u00e7\u00e3o PGRSS de tireoide+paratireoide<\/a><\/strong> \u2014 cap\u00edtulo dedicado a tireoidectomia + NIM-Response Medtronic + iPTH, paratireoidectomia + cintilografia 99mTc-MIBI, I-131 abla\u00e7\u00e3o + radioprote\u00e7\u00e3o CNEN-NN-3.05, TKI vandetanib Caprelsa\/cabozantinib Cometriq + RET selpercatinib Retsevmo\/pralsetinib Gavreto Lista C5.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tireoide oncol\u00f3gica gera RSS espec\u00edfico \u2014 tireoidectomia, paratireoide, I-131. PGRSS dedicado.<\/p>\n","protected":false},"author":3,"featured_media":2101,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[1954,1401,2918,1951],"class_list":["post-2102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-i-131","tag-iodo-radioativo","tag-paratireoide","tag-tireoide"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2102"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2102\/revisions"}],"predecessor-version":[{"id":4276,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2102\/revisions\/4276"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2101"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}